Gut Microbiota-Host Metabolomics Services
Gut microbiota–host metabolomics probes the complex metabolic dialogue between intestinal microbes and the host organism. Gut microbial communities produce key small molecules—such as short‑chain fatty acids (SCFAs), bile acids, indole derivatives, and vitamins—that profoundly influence host physiology, immunity, and metabolic regulation. Systemic metabolomes (e.g., serum, plasma) reflect both microbial activities and host responses, enabling an integrated view of microbe–host interactions and their implications in health and disease.
Why This Matters
🔹 Microbe–Metabolite Interaction Profiling
Capturing the interplay between microbial taxa and metabolite levels helps elucidate mechanisms underlying metabolic, inflammatory, and neurological conditions.
🔹 Insight into Host–Microbe–Disease Relationships
Correlating microbial shifts with changes in serum metabolites—such as glycerophospholipids and bile acids—supports biomarker discovery and reveals mechanistic insights into diseases like metabolic syndrome and cancer.
🔹 Cross-Disciplinary Applications
Applicable to nutrition, microbiome therapeutics, endocrinology, neurology, and clinical biomarker research—especially for conditions associated with gut dysbiosis and systemic metabolic imbalance.
Our Service Capabilities
✅ Comprehensive Metabolomic Profiling
Utilizing LC‑MS and GC‑MS platforms, our workflows quantify both gut-derived metabolites (e.g., SCFAs, secondary bile acids, indole compounds) and host metabolites (e.g., lipids, amino acids, organic acids) from stool, plasma, or serum samples.
✅ Multi-Omics Integration & Correlative Analysis
We offer integrated analyses that link microbial taxa with host metabolite changes using correlation networks, multivariate modeling, and network-based functional mapping.
✅ Pathway Enrichment & Mechanistic Mapping
Our analysis reveals how microbial activity influences key host pathways, such as bile acid metabolism, sphingolipid signaling, and SCFA-mediated immune modulation.
✅ Optional Metaproteomics Linkage
Advanced studies can include metaproteomics integration, providing deeper insights into microbial functionality and host–microbe interactions.
Typical Applications
- Clinical Biomarker Discovery
Identifying microbiota–metabolite signatures linked to metabolic syndrome, gastrointestinal diseases, cardiovascular risk, or early-stage cancer.
- Nutrition & Microbiome Interventions
Monitoring SCFA or bile acid profiles in response to dietary fiber, probiotics, synbiotics, or FMT (Fecal Microbiota Transplantation).
- Microbiome–Neurological Axis Studies
Examining gut–brain axis metabolites—such as GABA and tryptophan derivatives—for their association with neurological or behavioral outcomes.
- Ecological & Preclinical Models
Profiling host–microbe metabolic dynamics across species, animal models, or drug exposure studies to evaluate disease risk, aging, or treatment efficacy.
📦 Service Deliverables
- Quantitative output: Comprehensive metabolite tables detailing microbial and host metabolites.
- Correlative maps: Microbial taxa–metabolite association networks and statistical findings.
- Pathway insights: Host–microbe metabolic pathway diagrams and enrichment analysis.
- Data outputs: Raw and processed files in formats compatible with standard metabolomics and microbiome tools.
- Optional multi-omics report: Summary integrating metaproteomics, metagenomics, or transcriptomics (if provided).
👥 Who Should Use This Service?
This service is tailored for:
- Microbiome researchers
- Clinical investigators
- Nutritional scientists
- Biotech and pharma developers focusing on microbiome-based therapeutics
Contact Alfa Chemistry to initiate your gut microbiota–host metabolomics project. Whether your goal is to identify diagnostic biomarkers, support nutrition and microbiome intervention studies, or explore microbial impacts on host metabolic health—our platform and expertise are ready to support your research.
Please kindly note that our products and services are for research use only.
